Dr. Ahmed Hegazy


Dr. Ahmed Hegazy is a Physician by education and holds a Master’s degree in Pharmaceutical Medicine

(First Class Honor), Mini MBA, Medical Quality Management Diploma and Hospital Management Diploma.

  • He holds certificates on programs or courses from:
    • The George Washington University, USA
    • Columbia University, USA
    • Royal College of Physicians, UK
    • Hibernia College, Ireland
    • Uppsala Monitoring Center, WHO
  • He attended many trainings in leadership, strategic thinking, decision-making, brand planning, building efficient teams, high performance, accountability, communication skills, and persuasion and selling skills.
  • Moreover, He attended courses in Outcome Research and Health Economics, Drug discovery and development, Medical Ethics, Biostatistics, Research Methodology, Regulatory Affairs, Medical Affairs, and Pharmacovigilance.
  • Ahmed had been trained on ISO 9001-2015 Quality Lead Auditor Certification and Lean and Six Sigma Greenbelt Holder.

Dr. Ahmed received various awards and recognitions in innovation (Upjohn Award), achievements and others.

  • He has scientific publications in international journals.
  • Advisory Board, Committee member or member to International Scientific Journals, Associations and Conferences.
  • He is a member of Emirates Medical Association
  • He is a member of Emirates Health Economics Society
  • He is a member of the ISoP society and was a committee member of the ISoP Middle East Chapter.
  • He was invited as a speaker for hundreds of local, regional, international events and on TV as well as various online programs.
  • He attended numerous (~100s) conferences and events.

He owns more than 25 years of wealthy experience in Pharmaceutical Industry in different regions and

functions (sales, training, medical, marketing and PV).

  • He is an Expert in the Medical Affairs as he worked for 11 years in various positions in the Medical Affairs (Sr. Manager, Regional Manager and Head) in which he got experience in all MA roles, clinical research, governance, compliance, quality. He possesses strong medical knowledge in various therapeutic areas and many products’ portfolios. Currently, he conducts medical development programs.
  • He was holding a position of Head of Global Patient Safety for Africa, Middle East, Turkey, Russia & CIS countries (82 countries) for 7 years in Merck in which he was managing more than 16 subordinates based in 8 different countries.

Currently he is a:

  • Consultant for Medical Affairs, and Pharmacovigilance for Global, Regional and Local companies.
  • Senior Auditor for an international EU-based firm.
  • Speaker, Lecturer and Trainer for some colleges, companies, and health authorities.


Dr. Samia Kanawati

Samia currently serves as the Director of External Affairs, Policy & Communications at MSD GCC. She joined the company in August 2021 to lead to drive its external affairs function throughout the region.

A highly experienced and accomplished communications professional, Samia provides counsel on external affairs with an in-depth understanding of the key business imperatives facing the company and the value of strategic communications in achieving the company’s business objectives. Integral to the company’s reputation management, Samia develops media training programs, formulates key messages, and plans and implements an array of strategic communication initiatives for MSD across key markets in the GCC.

Before joining MSD, Samia served as the Area PR and Communications Lead for Allergan in Eastern Europe, Middle East and Africa (EEMEA) where she led Allergan’s internal and external communications across several practices, including public affairs, social and digital communications, CSR, patient advocacy group relationships, and crisis communications.

Prior to joining Allergan, Samia ran the regulatory and communications functions at Shire Middle East, where she built robust relationships with regional authorities and associations while also advising the company on brand strategies focused on consumer activations. During her tenure, she developed a detailed understanding of the legal framework, processes and legislative agendas of regional policy-makers and was influential in communicating Shire’s point of view in the region.

Samia’s career has seen her focus on private, government and NGO programmes, leading teams to implement ROI-driven communications strategies for both profit and NPO organisations.

Samia formerly served as GlaxoSmithKline’s regulatory and communications specialist for the Middle East and CIS regions, where she developed new digital communications platforms and channels to deliver functional priorities. From January 2005 until June 2013, she worked with KMP Pharmaceutical, where she was appointed to posts that included Pharmacist in Charge, Regulatory and Research & Development Assistant, as well as Head of Quality Control and Regulatory for the Levant region.

Samia graduated from the University of Jordan with a degree in Pharmacy. She holds an Executive MBA from Bradford University, School of Management in the United Kingdom, as well as a diploma in bio pharmacy from The Martin Luther University of Halle Wittenberg, Germany. She is fluent in English, Arabic and French.

Dr. Yousra Farid

Yousra a Regulatory Affairs and Commercial & Distribution Quality Assurance Head with over 16 years of diversified experience from various leadership positions in Regulatory Affairs and Quality Assurance within Health Authority as well as multinational organizations at both regional and local levels.

Yousra is currently leading Abbott-Gulf & Emerging Markets Regulatory Affairs & Quality Assurance. In her role in Abbott Established Pharmaceutical Division; Yousra is responsible for setting Regulatory Strategies for New Product Introduction, Geo-expansion, Licensing & Acquisition, Localization, Life cycle management, enhancement of promotional model, as well as RA risk mitigation and regulatory compliance.

Yousra has set effective regulatory strategies of external engagement including Health authorities, local distributors, trade associations and Third-Party Manufacturers. This is in addition to her Quality Assurance responsibilities of establishing and embedding Quality Management System within GEM. Institute of Technology, USA which upgraded her strategic thinking and enhanced her development.

Yousra is holding a bachelor of Pharmaceutical sciences from Cairo University and RAPS-DPC certification/USA-UAE and She has also completed the “New Leadership Program (NLP)”, by Harvard Business School and is currently enrolled in “Professional Diploma in Business Planning and Strategy”, by Rochester Institute of Technology, USA.

Dr. Najiba Al Shezawy

Dr. Najiba has Co-Foundaed Professional Regulatory Affairs (PRA), a leading healthcare regulatory consultancy in the Middle East since 2013. To further uphold the ethics and compliance standards within the industry, she has also persevered with Dubai Pharmacy College, industry experts and authorities to set up the GCC Regulatory Affairs (RA) Course, a first-of-its-kind certification, which educates graduates and professionals on the new career advancements and opportunities in this sector to become industry experts.

Mr. Jeffrey P. Kemprecos

Jeffrey P. Kemprecos, BA, MA, MIBS, is Director of Communications, Government Affairs & Market Access at GSK, a globally-leading healthcare company.


Mr. Kemprecos is based in Dubai, United Arab Emirates, where he leads GSK’s policy advocacy across a wide range of health and pharmaceutical industrial issues.


The scope of this work includes healthcare reform, intellectual property and trade-related issues, access to innovative medicines and vaccines, and regulatory harmonization.  Policies and legislation affecting competition, investment and innovation in the pharmaceutical sector constitute a primary focus.  Public policy work comprises two complementary missions—advocating legislation, regulations and policies that advance human health and strengthen the innovative medicines sector.


Mr. Kemprecos has worked in the innovative biopharmaceutical industry across a variety of countries and regions for almost 30 years, including the Eastern Europe, Middle East, Africa, Latin America and Asia/Pacific regions, leading government affairs, public policy, communications and market access teams responsible for up to 140 countries.


Mr. Kemprecos is currently serving in his second term as Chairman of the Intellectual Property Committee for the Pharmaceutical Research & Manufacturers Association in the Gulf (PHRMAG), Leader of the PHRMAG DOH Engagement Group, and is a member of the U.K. Business Council’s Healthcare and Life Sciences Working Group and the US Chamber of Commerce Gulf Business Council and Oman American Business Council. He also serves on the Abu Dhabi DOH Undersecretary’s Healthcare Council.


Mr. Kemprecos is a native of Massachusetts.  He speaks Arabic, English, Turkish and French.  He is the father of 3 vivacious daughters and an avid fan of vintage automobiles.